• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Financial planning during a pandemic: Part I

Video

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a possible second wave, as well as the potential financial repercussions the economy may face.

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak with Ophthalmology Times®' Sheryl Stevenson on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a potential second wave, as well as the financial repercussions the economy may face.

Related Videos
Early monoclonal antibody treatment of COVID-19 beneficial for high-risk COVID-19 patients
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
© 2024 MJH Life Sciences

All rights reserved.